Activated Clotting Time use with angiomax or bivalirudin

0 followers
0 Likes

Hello,


Our facility is seeking chest pain accreditation from American Cardiology Association and one of the guidelines is to run ACT with the administration of angiomax or bivalirudin.  ACA accreditation rep has provided us with literature and guidelines that are already in place for ACT measurement with angiomax or bivalirudin use.



  1. Are there any ACT devices validated for use with angiomax or bivalirudin?

  2. How are POC sites addressing ACT measurement protocols when angiomax or bivalirudin is used?


Thank you in advance for your input! 


Alka Arnold


 


 

3 Replies

There is no ACT that the FDA has cleared for use with any other anticoagulant than heparin.  That being said, both guidelines and drug labeling call for an ACT to be run when using most, if not all, alternative drugs.


The use of the ACT for monitoring these does officially make the test high complexity according to CLIA.  In my experience, many sites validate the test by performing in vitro dose response studies with the drug of choice and their local ACT.  In that way they demonstrate accuracy - there is a dose response, and precision by running multiple replicates of each sample.

Thank you Marcia and Penny for your prompt reply and helpful comments! 


 

Reply
Subgroup Membership is required to post Replies
Join POCT Listserv now
Alka Arnold
over 8 years ago
3
Replies
0
Likes
0
Followers
1584
Views
Liked By:
Suggested Posts
TopicRepliesLikesViewsParticipantsLast Reply
Labeling of POCT samples and devices
Felix Ortiz-Plaza
about 14 hours ago
10154
Kimberly Arnesen
about 14 hours ago
LeadCare II sample collection
Leslie Morman
about 16 hours ago
10128
Peggy Lindeman
about 16 hours ago
GH100 Training
Anita Belanger
about 17 hours ago
10151
Kenda Webb
about 16 hours ago